Suchergebnisse - "Kumar, Shaji K"

PubPharm (504)

1

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

2

An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Alodhaibi, I. | Ailawadhi, S. | Burbano, G. | +5

3

Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide

enthalten in: Blood cancer journal | 2024

von Goel, U. | Charalampous, C. | Kapoor, P. | +18

4

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

5

Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Goldman-Mazur, S. | Visram, A. | Rajkumar, S. | +14

6

New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma

enthalten in: Hematology/oncology clinics of North America | 2024

von Abdallah, N. | Kumar, S.

7

Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma

enthalten in: Blood cancer discovery | 2024

von Ghobrial, I. | Gormley, N. | Kumar, S. | +28

8

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma

enthalten in: JAMA network open | 2024

von Peipert, J. | Zhao, F. | Lee, J. | +14

9

Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone

enthalten in: Haematologica | 2024

von Ramasamy, K. | Bahlis, N. | Kumar, S. | +7

10

Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up

enthalten in: Leukemia | 2024

von Abdallah, N. | Witzig, T. | Kumar, S. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[51]